U.S. regulators snip red tape for medical devices to curb opioid crisis Medical Dialogues Bureau11 Nov 2018 10:40 AM ISTNew Delhi: Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win...
Glenmark to launch phase 1 trial in solid tumours for myeloma drug Medical Dialogues Bureau11 Nov 2018 10:20 AM ISTAn ongoing first-in-human, open-label, Phase 1 trial of GBR 1342 in multiple myeloma, is assessing the safety and tolerability of increasing doses of...
Israel's Intec Pharma eyes revenue from Parkinson's drug in 2019 Medical Dialogues Bureau11 Nov 2018 9:40 AM ISTNew Delhi: Tel Aviv, Israel's Intec Pharma, which is conducting a late-stage trial for its long-lasting pill to treat Parkinson's disease, expects to...
AstraZeneca returns to sales growth, led by cancer medicines Medical Dialogues Bureau11 Nov 2018 9:00 AM ISTLONDON: Strong demand for AstraZeneca's new drugs - especially those for cancer - drove a return to sales growth in the third quarter and the...
US FDA to strictly monitor sale of flavoured e-cigarettes Medical Dialogues Bureau10 Nov 2018 3:46 PM ISTThe new policy will apply to flavoured cartridge-style vaping products like Juul that have become popular among youths, not the open tank-style...
Fortis Q2 net loss widens to Rs 142 Crore; IHH transaction to be completed shortly Medical Dialogues Bureau10 Nov 2018 10:30 AM ISTNew Delhi: Fortis Healthcare has recently reported widening of its consolidated net loss to Rs 142 crore for the quarter ended September 2018, mainly...
Strides' subsidiary inks pact with SUDA Pharmaceuticals for migraine drug Medical Dialogues Bureau10 Nov 2018 10:00 AM ISTSumatriptan is one of the most widely used drugs for the treatment of an acute migraine in adults. SUD-001H is a first-in-class mint-flavoured oral...
Novartis division Sandoz recalls one lot of Losartan drug Medical Dialogues Bureau10 Nov 2018 9:45 AM ISTNew Delhi: Novartis has recently announced its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen...
Glenmark ties up with South Korea's SCD for ophthalmic products Medical Dialogues Bureau9 Nov 2018 10:00 AM ISTAccording to the pact, Glenmark and SCD will develop and commercialise six ophthalmic products in the US and Canada.New Delhi: Glenmark...
Lilly to consider more acquisitions like Rs 115 Crore Armo buy Medical Dialogues Bureau9 Nov 2018 9:40 AM ISTNew Delhi: Eli Lilly and Co will consider more acquisitions similar to its $1.6 billion purchase of cancer drug developer Armo Biosciences earlier...
AstraZeneca sells older asthma, rhinitis drugs for $350 mln Medical Dialogues Bureau9 Nov 2018 9:05 AM ISTLONDON: AstraZeneca is selling three older drugs for asthma and rhinitis for at least $350 million as the company continues a strategy of divesting...
NPPA fixes ceiling price of Nitrous Oxide, Oxygen, Details Medical Dialogues Bureau8 Nov 2018 3:01 PM ISTThrough a recent notification NPPA, Department of pharmaceuticals has fixed the ceiling price of Nitrous oxide as well as oxygen. The ceiling...
